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ABSTRACT
Sexual differentiation in Drosophila is regulated
through alternative splicing of doublesex. Female-
specific splicing is activated through the activity of
splicing enhancer complexes assembled on multi-
ple repeat elements. Each of these repeats serves as
a binding platform for the cooperative assembly of a
heterotrimeric complex consisting of the SR pro-
teins Tra, Tra2 and 9G8. Using quantitative kinetic
analyses, we demonstrate that each component of
the enhancer complex is capable of recruiting the
spliceosome. Surprisingly, Tra, Tra2 and 9G8 are
much stronger splicing activators than other SR
protein family members and their activation poten-
tial is significantly higher than expected from their
serine/arginine content. 9G8 activates splicing not
only through its RS domains but also through its
RNA-binding domain. The RS domains of Tra and
Tra2 are required but not sufficient for efficient
complex assembly. Thus, the regulated assembly of
the dsx enhancer complexes leads to the generation
of an extended activation domain to guarantee the
‘all or none’ splicing switch that is required during
Drosophila sexual differentiation.
INTRODUCTION
In higher eukaryotes, alternative pre-mRNA splicing is used
as a common pathway to regulate the expression of genes
(1–3). For classical cases of alternative splicing, it was
shown that cis-acting RNA sequence elements increased
exon inclusion by serving as binding sites for the assembly
of multi-component splicing enhancer complexes. Because
these sequence elements were usually located within the
regulated exon, they were deﬁned as exonic splicing
enhancers (ESEs) (2,4). It has been demonstrated that the
recognition of weak splice-site signals can be augmented sig-
niﬁcantly by the presence of ESEs, and, in contrast, that ESEs
have little or no detectable effect on the activation of strong
splice sites that conform to the consensus sequence (5,6).
ESEs are usually recognized by at least one member of the
essential serine/arginine (SR)-rich protein family and recruit
the splicing machinery to the adjacent intron (2,4,5,7). SR
proteins act at several steps during the splicing reaction
(8–14) and require phosphorylation and dephosphorylation
for spliceosomal assembly (15,16). Interestingly, SR protein-
binding sites are present not only within alternatively spliced
exons but also within the exons of constitutively spliced pre-
mRNAs (17,18). It is therefore likely that SR proteins bind to
sequences found in most, if not all, exons.
Although arginine-serine (RS) domains clearly function
as activation domains, the mechanism by which they do so
remains unclear. One model for the mechanism of SR protein
action proposes that the RS domain of an enhancer-bound
SR protein interacts directly with other splicing factors con-
taining an RS domain, thus facilitating the recruitment of
the spliceosome (5). An alternative model was suggested by
experiments demonstrating that RS domains of SR proteins
within the functional spliceosome contact the pre-mRNA
(19,20). The sequential character of these contacts suggested
that RS domain interactions with RNA promote spliceosome
assembly. Irrespective of the mechanism of action, ESEs
facilitate the recruitment of spliceosomal components to the
regulated splice site (2,21,22). More recently, it was demon-
strated that ESEs promote the recognition of both exon/intron
junctions within the same step during exon deﬁnition. These
results suggested that ESEs recruit a multi-component
complex that minimally contains components of the splicing
machinery required for 50 and 30 splice-site selection
(23,24). Thus, ESEs function as general activators of exon
recognition.
The relative activities of SR proteins depend on their afﬁn-
ity for splicing enhancers and the strength of their activation
domains. Using an MS2 tethering approach it was possible to
uncouple the spliceosomal recruitment and the RNA-binding
activities of SR proteins (25). This system allowed a careful
quantitative comparison of the activity of several RS domains
(26) to demonstrate that the strength of ESEs is determined
by the relative activities of the bound SR proteins, by the
number of SR proteins assembled on ESEs, and by the
distance between the enhancer and the intron. A mechanisti-
cally important observation was that the splicing activity of
the bound SR proteins was proportional to the number of
SR repeats contained within the RS domain of the proteins
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Genes involved in Drosophila sex determination are pro-
totypes for the study of positive and negative control of alter-
native splicing (27). The best characterized are the doublesex
(dsx) and fruitless (fru) genes, in which the use of two alter-
native 30 (dsx)o r5 0 (fru) splice sites leads to the expression
of male- or female-speciﬁc gene products that initiate gender-
speciﬁc sexual differentiation and orientation (28,29).
Female-speciﬁc splicing of dsx requires the production of
two proteins, Transformer (Tra) and Transformer2 (Tra2),
and an ESE (dsx ESE) consisting of six repeat elements
(dsxRE) (30–32). Similarly, female-speciﬁc splicing of
fru depends on Tra, Tra2 and an ESE (fru ESE) consisting
of three repeat elements identical to dsxREs (24,33). Both
Tra and Tra2 contain RS-rich domains. Previous in vitro stud-
ies in HeLa extracts demonstrated that Tra, Tra2 and the SR
protein 9G8 (the human homologue of Drosophila RBP1)
assemble cooperatively on each dsxRE (34,35). While 9G8
and Tra2 bind to the 50 and 30 half, respectively, Tra appears
to contact RNA only very weakly, if at all. Although the
identity of the factors that make up the dsx enhancer complex
has been revealed, it is currently unknown whether more than
one molecule of each component is required for assembly.
It is also unclear which one of the three proteins that make
up a dsxRE complex is critical in communicating splice-site
recognition to the splicing machinery. Each protein contains
at least one SR domain that may be involved in crucial
protein–protein interactions. Therefore, it is possible that
the three proteins combined or one in particular function to
recruit the splicing machinery.
Here we evaluated in detail the potency of the dsxRE. By
taking advantage of the MS2-fusion approach, we were able
to demonstrate that each of its components has an activation
potential that is signiﬁcantly higher than expected from SR
dinucleotide content alone. Our quantitative analysis shows
that the SR domains of each component are necessary
but not sufﬁcient for maximal activation. For 9G8, the
RNA-binding domain contributes considerably to splice-site
activation. Furthermore, each dsxRE enhancer complex is
signiﬁcantly more potent than canonical SR proteins. These
experiments demonstrate that the splicing enhancer complex
assembled on dsxREs has evolved to possess exceptional
activation potency as is required to induce a complete switch
in sex-speciﬁc alternative pre-mRNA splicing for the dsx and
fru genes.
MATERIALS AND METHODS
RNA
The plasmids, pdsx70(MS2)2, pdsx200-MS2, pdsx200(MS2)2,
pdsx300(MS2)2, pdsx300-1RE, pdsx300-2RE, pdsx300-4RE
and pdsx300-5RE, were previously described as transcrip-
tion templates (25,35). Capped,
32P-labeled RNAs were tran-
scribed with T7 RNA polymerase and gel-puriﬁed before use
as splicing substrates (36).
Proteins
The expression and puriﬁcation of MS2-fusion proteins was
as described previously (25). The coding sequence of tra,
tra-2 or 9G8 was ampliﬁed by PCR such that a BamHI site
was inserted at the 50 end and a HindIII site at the 30 end.
The puriﬁed fragment was inserted into pHIS-BIVT-MS2
vector (25), and digested to generate the corresponding
baculovirus transfer vector.
All recombinant baculoviruses were generated in serum-
free culture as described by the manufacturer (Gibco-BRL).
Each protein was expressed in infected Sf9 cells for 3 days
and batch puriﬁed under modiﬁed denaturing conditions.
Brieﬂy, the lysed cell protein pellet was extracted in a 6 M
guanidine-HCl, pH 8, solution containing followed by the
addition of Ni-NTA agarose slurry for binding to the
6·His-MS2-fusion protein. The slurry was funneled into a
column and washed with an 8 M urea, pH 8, solution contain-
ing 20 mM imidizole. The MS2-fusion protein was eluted
with stepwise increasing concentrations of imidizole. The
protein was dialyzed against BC850 splicing buffer described
previously (37).
In vitro splicing assays
Conditions for in vitro splicing reactions were 30% HeLa
nuclear extract, 1 mM ATP, 20 mM creatine phosphate,
3.2 mM MgCl2, 5 U RNasin (Promega), 1 mM DTT,
72.5 mM KCl, 3% polyvinyl alcohol (MW 30–70 KDa)
and 12 mM HEPES, pH 7.9. Reactions for Tra/Tra2-
dependent or MS2-fusion protein-dependent substrates were
performed in the absence or presence of saturating amounts
of recombinant protein ( 400 nM), unless otherwise stated.
Splicing reactions were performed for the indicated times at
30 C. Following incubation, reactions were proteinase K
digested, phenol/chloroform extracted and ethanol precipi-
tated before PAGE separation. Bands were visualized and
quantiﬁed using PhosphorImager analysis (Bio-Rad). Percent
spliced is deﬁned as spliced products/(unspliced product +
spliced products). The background was determined individu-
ally for each lane since the total number of substrate and
product counts varied throughout a time course. Rate con-
stants for each time course were determined as previously
described (36). Experiments were performed at least three
times. Variations between experiments were within 2-fold.
RESULTS
The role of Tra, Tra2 and 9G8 in splice-site activation and
dsxRE complex formation are unknown. It is possible that
only one protein factor of each dsxRE complex may be
required for interactions with the splicing machinery while
the others may be essential for complex assembly and/or to
stabilize the protein network. We have made use of an
MS2 hybrid approach to evaluate this possibility. Tra, Tra2
and 9G8 were fused with the MS2 bacteriophage coat protein
and overexpressed in baculovirus infected Sf9 cells. A dsx
pre-mRNA containing the cognate MS2-binding site in
place of the dsx splicing enhancer was then used as a splicing
substrate, thus placing the artiﬁcial enhancer site at various
distances from the regulated intron, ranging from 70 to
300 nt. The rationale for this approach is to generate an
extremely stable and speciﬁc interaction site for each of the
enhancer complex components in isolation from each other.
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fusion of MS2 to the N-terminus of Tra or Tra2 interfered
with the protein’s ability to activate dsx splicing from within
the dsx ESE. Time course experiments demonstrated that
both fusion proteins were able to activate female-speciﬁc
splicing of the reporter substrate dsx300-5RE to extents simi-
lar to those measured in the presence of wt proteins (Figure 1
and Table 1). Observed rates of splicing were measured to
be within 2-fold. We conclude that the MS2-fusion of
Tra and Tra2 does not signiﬁcantly inhibit dsx enhancer
complex function. Additional experiments were carried out
to determine the activation potential of one of the multiple
dsxREs that make up the dsx ESE. In agreement with previ-
ous observations, the observed rate of intron removal
increased as the number of repeat elements present within
the dsx ESE increased (35). The average rate of splicing for
one dsxRE was measured to be 0.11 h
 1.
The activation potential of individual components
of the dsxRE
To determine how efﬁcient each fusion protein is in activat-
ing female-speciﬁc intron removal, the rate of splicing was
measured for the dsx300-(MS2)2 substrate at saturating con-
centrations of fusion protein. Four hybrid proteins interact
with dsx300-(MS2)2 because MS2 binds the MS2-hairpin as
a dimer. The rate analysis shows that each recombinant
enhancer protein is capable of independently activating
splicing at the native distance when tethered to the RNA
(Figure 2). Control experiments showed that, at the reaction
conditions used, intron removal was only observed if the sub-
strate contained a functional MS2-hairpin motif. Deletion or
mutation of the MS2-hairpin motif did not activate intron
removal, indicating that the recombinant fusion proteins
used did not activate splicing through non-speciﬁc RNA
interactions mediated through either their native or the MS2
RNA recognition motif (RRM) (data not shown). Interest-
ingly, when evaluated at 300 nt downstream from the regu-
lated splice site, the splicing activity observed for RS
domain fusion protein MS2–RS
(SC35/SC35), previously identi-
ﬁed as a strong activator in the context of this MS2-hairpin
system (26), was  10-fold lower than the activity measured
for each of the full-length fusion proteins tested (Figure 2B
and C). We conclude that each dsxRE complex component
(Tra, Tra2 and 9G8) has the potential to contribute to the
overall splicing potential of the multi-component dsx
enhancer complex.
To further evaluate the activation potential of Tra, Tra2
and 9G8, we carried out comparative splicing reactions
with a variety of MS2-fusion proteins. In agreement with pre-
vious observations, fusing the RS domains of the SR proteins
SRp55, SC35, ASF/SF2 and 9G8 to MS2 resulted in strong
activation when tethered close to the regulated splice site
(25) (Table 2). However, the activation potential of these
SR fusion proteins decreased dramatically when located
where the dsx ESE usually resides,  300 nt downstream of
the female-speciﬁc splice site. At this distance, the activation
potential of the MS–RS fusion proteins increased propor-
tional to the number of SR dipeptide repeats (Figure 3). Strik-
ingly, tethered Tra, Tra2 or 9G8 are signiﬁcantly more active
than one would predict from their SR content. Furthermore,
the splicing activity of the dsxRE complex is close to the
sum of the activation potential measured for each individual
component. These observations are consistent with the idea
that each component of the dsxRE complex contributes func-
tionally to the recruitment of the spliceosome to the regulated
splice site. We conclude that the components of the dsxRE
splicing complex are signiﬁcantly more active than the RS
Figure 1. Recombinant MS2-fusion proteins activate native enhancer elements for female-specific dsx splicing. (A) Schematic representation of recombinant
fusion proteins. The RNA-binding domain of the bacteriophage MS2 coat protein was fused in-frame with the entire coding sequence of either Transformer (Tra)
or Transformer2 (Tra2). (B) Schematic representation of the dsx mini-gene RNA substrate used for in vitro splicing assays. Open boxes represent exons 3 and 4
of the dsx gene. 50 and 30 splice sites (ss) are labeled. Dashes represent the 13 nt repeat elements (RE) of the native dsx enhancer located  300 nt downstream of
the 30 splice site. (C) In vitro splicing assays were performed in the presence of recombinant Tra and Tra2 proteins or MS2–Tra and MS2–Tra2 proteins to
evaluate the potency of each recombinant fusion protein. Diagrams to the right indicate unspliced or spliced RNA.
Table 1. Splicing rates promoted by recombinant Tra and Tra2
RNA substrate
dsx300-1RE dsx300-2RE dsx300-4RE dsx300-5RE
Tra + Tra2
a 0.11 0.31 0.33 0.39
MS2–Tra + Tra2 nd nd nd 0.38
Tra + MS2–Tra2 nd nd nd 0.19
All rate constants are expressed in units of h
 1. Each value is the average from
at least three independent splicing reactions consisting of 7–8 time points over
a 4h time period.To deriverate constants, the dataat time pointsfollowingthe
lag were fit to a first-order rate equation (43). Experimental error for the rate
constants is within 50%. nd, not determined.
aAverage splicing rate per dsxRE with Tra + Tra2 ¼ 0.11 ± 0.05 h
 1.
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The domains responsible for exceptional potency
of dsx enhancer proteins
To determine which domains of Tra, Tra2 and 9G8 are
responsible for the strong splicing activation, we performed
a series of truncation and deletion experiments. In the case
of 9G8 we compared full-length 9G8 with an RRM deletion
and an RRM/Zinc-knuckle deletion. Splicing analysis of the
substrate dsx200-(MS2)2 indicated that a signiﬁcant drop in
activity was observed when the Zinc-knuckle domain was
deleted from the fusion protein (Figure 4). Although the pres-
ence of the RS domains is required for splicing activity (25),
our results suggest that the Zinc-knuckle and the RS domain
of 9G8 cooperate in promoting splicing. However, the
mechanisms for this cooperation are currently unclear.
Similar experiments were carried out with wt and mutant
versions of Tra and Tra2 (Figure 5 and Table 2). The results
show that both RS domains of Tra2 contribute signiﬁcantly to
splicing activation, especially at a distance of 300 nt from the
regulated splice site. However, the loss of the N-terminal RS
domain (30-fold reduction) is much more detrimental to the
Figure 2. Individual enhancer complex proteins activate the female-specific dsx 30 splice site. (A) Schematic representation of a dsx mini-gene RNA substrate
with two synthetic MS2-hairpin enhancer elements positioned  300 nt downstream of the female-specific 30 splice site. Four RS fusion proteins are expected to
interact with dsx300-(MS2)2 because MS2 binds the MS2-hairpin RNA as a dimer. (B) In vitro splicing assays were performed in the presence of saturating
amounts of recombinant MS2-fusion proteins. Diagrams to the right indicate unspliced and spliced products. Average splicing rates for each MS2-fusion protein
are listed below the corresponding gel. (C) The percent spliced is plotted as a function of time to determine a rate of splicing for each fusion protein tested. Filled
circles indicate MS2–Tra2, open circles indicate MS2–Tra, filled diamonds indicate MS2–9G8 and filled triangles indicate MS2–2RS
(SC35/SC35).
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(4-fold reduction). As was observed for 9G8, the RS domains
of Tra2 cooperate in mediating splicing activation. This is
because the sum of the RS1 and RS2 activation potential
is considerably less than what was observed for full-
length Tra2 (Figure 5A and Table 2). We conclude that
both RS domains of Tra2 are required for maximal splicing
activation.
The architecture of Tra is different from Tra2 as Tra
does not contain a recognizable RNA-binding domain.
The N-terminal RS domain is followed by a C-terminal
proline-rich domain (Figure 5B). To determine whether the
proline-rich domain contributes to splice-site activation, we
compared the splicing efﬁciency of the dsx300-(MS2)2 sub-
strate in the presence of Tra fused to MS2, in the presence
of a proline-rich domain deletion of Tra fused to MS2, or
in the presence of an RS domain deletion of Tra fused to
MS2. Splicing experiments indicated that the deletion of
the RS domain reduced splicing efﬁciency to background lev-
els. In contrast, deletion of the proline-rich domain did not
affect the activation potential of Tra (Figure 5B). We con-
clude that the RS domain of Tra is essential and sufﬁcient
Table 2. Splicing rates promoted by MS2–RS fusion proteins
RNA substrate
Fusion protein No. of RS/SR dsx70-(MS2)2 dsx200-MS2 dsx200-(MS2)2 dsx300-(MS2)2
MS2–2RS
(SC35/SC35) 55 1.7 0.026 nd 0.016
MS2–2RS
(SC35/SF2) 43 1.5 0.027 nd 0.013
MS2–2RS
(SF2/SF2) 30 1.9 0.020 nd 0.011
MS2–RS
(p55) 38 Nd 0.016 nd 0.009
MS2–RS
(SC35) 28 Nd 0.016 nd 0.019
MS2–9G8 34 1.4 0.41 0.72 0.14
MS2–ZnRS
(9G8) 31 Nd 0.28 0.52 0.091
MS2–RS
(9G8) 31 0.92 0.016 nd 0.014
MS2–Tra 17 1.0 0.18 0.60 0.24
MS2–Tra
(DPro) 17 Nd nd 0.61 0.24
MS2–Tra
(DRS) 4 nd nd 0.004
a 0.015
MS2–Tra2 22 0.59 0.29 0.74 0.30
MS2–Tra2
(DRS1) 9 0.067 nd 0.014 0.010
MS2–Tra2
(DRS2) 14 0.46 nd 0.17 0.068
Allrateconstantsareexpressedinunitsofh
 1.Eachvaluewasdeterminedfromatleastthreeindependentsplicingreactionsconsistingof7–8timepointsovera4h
time period. To derive rate constants, the data at time points following the lag were fit to a first-order rate equation (43). Experimental error for the rate constants is
within 50%. nd, not determined.
aThe splicing of the dsx200-(MS2)2 substrate was not significantly above background.
Figure 3. Individual dsx enhancer complex proteins are exceptionally potent activators relative to their RS content. The average splicing rate for the dsx300-
(MS2)2 RNA substrate is plotted as a function of the RS/SR dipeptide content for each MS2-fusion protein (data from Tables 1 and 2). The line indicates a linear
fit for five MS2–RS domain proteins previously evaluated for splicing efficiency (25). Filled triangles indicate MS2–RS domain proteins utilized in these
experiments. The open triangle denotes MS2–RS
(9G8). Filled circles indicate the dsx enhancer MS2-fusion proteins. The RS content for complexes formed on the
dsx300-(MS2)2 substrate containing two MS2-binding sites is four times that of each hybrid protein because MS2 binds the MS2-hairpin RNA as a dimer. The
filled diamond represents the average splicing rate of four dsxRE complexes and assumes one molecule of each enhancer protein (Tra, Tra2 and 9G8) is bound to
a single 13 nt repeat element.
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the dsx300-(MS2)2 substrate.
The components of the dsxRE are functionally unique
relative to other RS domain proteins
Our kinetic analysis indicated that the components of each
dsxRE are more potent splicing activators compared with
canonical SR proteins. To evaluate the activation potential
of Tra, Tra2 and 9G8 at various distances from the regulated
splice site, we carried out in vitro splicing reactions with sub-
strates that harbor MS2-hairpin domains at various distances
from the regulated splice site. In agreement with previous
observations (26), a large decrease in splice-site activation
was observed for the test substrates that were activated by
MS2–RS fusion proteins (Figure 6 and Table 2). Moving
the MS2-hairpin from 70 to 300 nt downstream from the
female-speciﬁc splice site resulted in a >50-fold reduction
in splicing efﬁciency. However, substituting MS2–Tra
for MS2–2RS
(SC35/SC35) in the same experiment resulted in
only a 4-fold reduction in the observed rate of splicing. Simi-
lar trends were also determined for MS2–9G8 and MS2–Tra2
(Table 2). These results show that the components of the
dsxRE complex are highly potent activators, even at a
distance of 300 nt from the regulated splice site.
DISCUSSION
The activation potential of the dsxRE
The formation of splicing enhancer complexes is essential for
the activation of most constitutive and differential splicing
patterns. To gain insights into the mechanisms of enhancer
complex assembly and function, we investigated the role
of Tra, Tra2 and 9G8 in the recruitment of the splicing
machinery. Each dsxRE serves as a binding platform for
the cooperative assembly of multiple multi-component splic-
ing enhancer complexes consisting of the SR proteins 9G8,
Tra and Tra2 (34,35). To determine the activation potential
of the SR proteins that comprise the dsxRE, we generated a
series of fusion proteins between the MS2 coat protein and
Tra, Tra2, 9G8 or other SR proteins. Because MS2 interacts
speciﬁcally with a hairpin loop, we were able to form stable
interactions of individual components of the dsxRE complex
in isolation. Splice-site activation was tested in vitro with
each of the fusion proteins present at concentrations that satu-
rate binding to the MS2-hairpin but that did not support non-
speciﬁc RNA binding. Using this tethering approach, we
demonstrated that each fusion protein in isolation was able
to activate splicing. However, they differed drastically in
the extent of activation. A previous work indicated that
enhancer-dependent splice-site activation correlates with the
number of RS dipeptide repeats present in each protein
(25). Tra, Tra2 and 9G8 do not follow this trend, as they acti-
vate splicing much more efﬁciently than other SR proteins
(Figure 3). Our analysis demonstrated that in the context of
dsx, Tra, Tra2 and 9G8 are highly active splicing activators
that may use mechanisms of activation distinct or in addition
to those described for canonical SR proteins.
The roles of 9G8 in dsx splicing
Tra, Tra2 and 9G8 mutants were generated to determine
which domains are responsible for their high activation
potential. In all cases, the presence of their RS domains
was required for maximal splice-site activation. However,
the overall contributions of the RS domains tested differed
signiﬁcantly. In the case of the SR protein 9G8, the most sig-
niﬁcant drop in activity was observed when the Zn-knuckle
was deleted from the fusion protein. These observations
suggest that the Zn-knuckle domain of 9G8 contains a stretch
Figure 4. The Zinc-knuckle and RRM domains add significant potency to 9G8 splicing activation. (A) Schematic representation of MS2–9G8 recombinant
fusion proteins. MS–9G8 is full-length 9G8 fused in-frame to the bacteriophage MS2 coat protein. Likewise, MS2–ZnRS
(9G8) contains only the Zinc-knuckle and
RS domain of 9G8, and MS2–RS
(9G8) contains only the RS domain of 9G8, fused in-frame to the MS2 protein. (B) Schematic representation of the dsx mini-gene
RNA substrate used (dsx200-MS2) with one synthetic MS2-hairpin enhancer element positioned  200 nt downstream of the female-specific 30 splice site.
(C) In vitro splicing assays were performed with a dsx mini-gene RNA substrate containing a single MS2-hairpin  200 nt from the 30 splice site (dsx200-MS2) in
the presence of recombinant MS2-fusion proteins. Diagrams to the right indicate unspliced, spliced or intermediate products. Average splicing rates for each
MS2-fusion protein are listed below the corresponding gel (data from Table 2).
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is unknown how the effect is mediated. Perhaps, the Zn-
knuckle domain could be involved in direct interactions
with components of the splicing machinery. Alternatively,
the presence of the Zn-knuckle could induce a speciﬁc struc-
tural fold within the RS domain that renders it more potent
or accessible for phosphorylation and dephosphorylation,
thus overcoming the intrinsically disordered structure of RS
domains (38).
Previous studies suggested that the RNA-binding domain
of the SR protein ASF/SF2 is directly involved in mediating
spliceosomal assembly (39). It is possible that the RRM
of ASF/SF2 makes up a binding platform involved in speciﬁc
protein–protein interactions. Alternatively, the RRM-
mediated interaction of ASF/SF2 with the pre-mRNA may
modulate splicing by competing with the binding of other
regulatory factors, thus suggesting that antagonism between
positive and negative splicing factors may be derived from
Figure 5. The RS domains of Tra and Tra2 are essential for splicing activation. In vitro splicing assays were performed with the dsx300-(MS2)2 RNA substrate in
the presence of the recombinant MS2-fusion proteins represented by schematic diagrams. (A) Splicing activities for full-length Tra2 (MS2–Tra2) indicated by
filled circles, RS1-deletion mutant (MS2-Tra2DRS1) indicated by open diamonds and RS2-deletion mutant (MS2-Tra2DRS2) indicated by open circles are
plotted as a function of time. (B) Splicing activities for full-length Tra (MS2–Tra) indicated by filled circles, RS-deletion mutant (MS2-TraDRS) indicated by
open diamonds and proline-rich region-deletion mutant (MS2-TraDPro) indicated by open circles are plotted as a function of time. Average splicing rates for
these recombinant proteins are listed in Table 2.
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Our observation that the Zn-knuckle of 9G8 drastically
increases 9G8’s activation potential is more consistent with
the formation of a binding platform involved in speciﬁc
protein–protein interactions. This is because all fusion
proteins tested interacted with the same MS2-hairpin struc-
ture on the pre-mRNA. Thus, the potent splice-site activation
of 9G8 is mediated not only by the RS domain but also by
portions of its RRM.
The roles of Tra and Tra2 in dsx splicing
In the case of Tra2, both RS domains were shown to con-
tribute to splicing activation, however, the N-terminal RS1
domain was at least 5-fold more potent than the C-terminal
RS2 domain. These observations appear to be in disagree-
ment with results obtained from mutational analyses carried
out in transgenic ﬂies (41). It was demonstrated that the dele-
tion of RS2 abolishes sex-speciﬁc dsx splicing in ﬂies while
the deletion of RS1 had only marginal effects. Interestingly,
the same study also showed that RS2 deletions of Tra2 sig-
niﬁcantly reduced protein interactions with other SR proteins.
However, the results from both studies can be reconciled
by proposing that RS2 of Tra2 is essential for the formation
of the heterotrimeric complex on each of the dsxREs. This
model suggests that in the absence of RS2 no stable
heterotrimeric complex forms and female-speciﬁc splicing
of dsx is severely compromised. In the absence of RS1,
heterotrimeric complex formation is still possible and the sta-
ble recruitment of 9G8 and Tra is sufﬁcient to mediate
female-speciﬁc splicing of dsx. Thus, RS1 and RS2 of Tra2
may have distinct roles in activating female-speciﬁc splicing
of dsx. RS1 may be involved in recruiting spliceosomal com-
ponents, whereas RS2 may be engaged in protein–protein
interactions that ensure high stability of the heterotrimeric
complex assembled on each dsxRE (Figure 7).
In the case of Tra, the mutational analysis clearly indicates
that the RS domain is sufﬁcient to promote high levels of
splice-site activation. No splicing activity was observed for
the proline-rich domain of Tra, suggesting that this domain
is not involved in direct interactions with the spliceosome.
Spliceosome activation by the dsx ESE
Because none of the fusion proteins alone, but the sum of all,
can account for the activation potential of the fully assembled
dsx enhancer complex (Figure 3), we propose that each com-
ponent of the heterotrimeric enhancer complex participates in
interactions with the spliceosome, generating an extended
activation domain that is stabilized through the cooperative
interactions between the components of the dsxRE (34,35)
(Figure 7). Perhaps, this hypothesis could have been tested
more directly by generating MS2-fusion proteins linking the
SR domains of Tra, Tra2 and 9G8 or by creating a fusion
between MS2 and all three full-length proteins. However,
such fusion experiments did not guarantee to fully reproduce
the cooperative interactions between RS1 and RS2 of Tra2
nor the contributions of the Zn-knuckle domain of 9G8.
Tra and Tra2 regulate sexual differentiation and behavior
of Drosophila through alternative splicing of the dsx and
fru genes (42). To avoid mixed expression of male- and
female-speciﬁc transcription factors, the regulation of dsx
and fru alternative splicing requires tight control and an efﬁ-
cient switch between male and female splicing. The composi-
tion and location of the dsx ESE 300 nt downstream of the
regulated splice site is conserved among different Drosophila
species, suggesting evolutionary inﬂuences in generating a
unique exon architecture (43). Indeed, it was shown that the
regulation of dsx splicing could only be achieved if the dsx
ESE is 300 nt downstream of the regulated splice site. Con-
stitutive activation was observed when the dsx ESE was
within 100 nt of the splice site (44). Thus, the dsx ESE
must have evolved to communicate female-speciﬁc splice-
site recognition with high efﬁciency from a distance that usu-
ally does not support splicing regulation. We previously
demonstrated that the cooperative assembly and the multiple
presence of the dsxRE are contributing factors in achieving
the elevated potency required for female-speciﬁc splicing
(35). The analysis presented here reveals an additional
mechanism to ensure efﬁcient splice-site selection. Each
Figure 7. Extended activation domain of the dsxRE. The heterotrimeric
complex that binds each dsxRE generates a potent splicing activation domain
that is composed of contributions from each complex member. The RS
domains of 9G8, Tra and the RS1 domain of Tra2 may be involved in
mediating spliceosomal recruitment to the regulated splice site. RS2 may be
involved in securing complex stability through essential protein–protein
interactions.
Figure 6. Tra, Tra2 and 9G8 are more potent female-specific dsx splicing
activators at greater distances than other RS domain-containing proteins.
Representative splicing rates for MS2–Tra, represented by filled circles, and
MS2–2RS
(SC35/SC35) represented by filled triangles. Observed rates of
splicing are plotted as a function of the distance between the enhancer
elements and the female-specific dsx 30 splice site.
Nucleic Acids Research, 2006, Vol. 34, No. 22 6619repeat element within the dsx ESE recruits the unusually
effective splicing activators Tra, Tra2 and 9G8 to form a
splicing enhancer complex of great potency. Thus, multiple
enhancer complexes with high stability and elevated activity
ensure practically exclusive alternative splicing of dsx
and fru.
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